A major global medical breakthrough for thalassemia patients as the US drug regulator FDA approves Mitapivat, the first oral medicine for the genetic blood disorder. This new drug offers hope for a ...
In a major medical breakthrough, the US FDA has approved a new oral drug for Thalassemia, offering hope for a transfusion-free life. Discussing the development, Dr Sanjeev Bagai, Chairman of Nephron ...